neihulizumab (ALTB-168) - AltruBio
https://ash.confex.com/ash/2024/webprogram/Paper202199.html
 
Katsuyoshi Takata, MD, PhD1; Hidekazu IIoka2; Shuta Tomida, PhD3; Yuting Liu4; Shujiro Okuda4; Hiroyuki Usuda5; Takashi Kawasaki6; Akihiro Kitadate, M.D., Ph.D.7; Naoto Takahashi, MD, PhD8; Gerben Duns, PhD9; Yasuharu Sato, PhD10; Christian Steidl, MD, PhD9; Daisuke Ennishi, MD, PhD11
 
Nov 6, 2024
 
Prev Next